BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34176753)

  • 1. Healthcare utilization and spending among older patients diagnosed with Non-Hodgkin lymphoma.
    Kenzik KM; Williams GR; Bhakta N; Robison LL; Landier W; Goyal G; Mehta A; Bhatia S
    J Geriatr Oncol; 2021 Nov; 12(8):1225-1232. PubMed ID: 34176753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cause-specific mortality among Medicare beneficiaries with newly diagnosed non-Hodgkin lymphoma subtypes.
    Hester LL; Park SI; Wood WA; Stürmer T; Brookhart MA; Lund JL
    Cancer; 2019 Apr; 125(7):1101-1112. PubMed ID: 30548238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of Healthcare Utilization and Spending Among Homebound Older Adults in the USA: an Observational Study.
    Oseroff BH; Ankuda CK; Bollens-Lund E; Garrido MM; Ornstein KA
    J Gen Intern Med; 2023 Mar; 38(4):1001-1007. PubMed ID: 35945471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous-thromboembolism and associated health care utilization in elderly patients with diffuse large B cell lymphoma.
    Gangaraju R; Davis ES; Bhatia S; Kenzik KM
    Cancer; 2022 Jun; 128(12):2348-2357. PubMed ID: 35363373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Outcomes, Treatment Toxicity, and Health Care Utilization in Older Adults with Aggressive Non-Hodgkin Lymphoma.
    Johnson PC; Yi A; Horick N; Amonoo HL; Newcomb RA; Lavoie MW; Rice J; Reynolds MJ; Ritchie CS; Nipp RD; El-Jawahri A
    Oncologist; 2021 Nov; 26(11):965-973. PubMed ID: 34327767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Comorbidity Models Within a Population-Based Cohort of Older Adults With Non-Hodgkin Lymphoma.
    Gordon MJ; Duan Z; Zhao H; Nastoupil L; Iyer S; Ferrajoli A; Danilov AV; Giordano SH
    JCO Clin Cancer Inform; 2024 Apr; 8():e2300223. PubMed ID: 38684043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuity of Care and Health Care Utilization in Older Adults With Dementia in Fee-for-Service Medicare.
    Amjad H; Carmichael D; Austin AM; Chang CH; Bynum JP
    JAMA Intern Med; 2016 Sep; 176(9):1371-8. PubMed ID: 27454945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare utilization and cost of care in elderly breast cancer patients enrolled in SWOG clinical trials.
    Hershman DL; Till C; Wright JD; Accordino M; Vaidya R; Barlow WE; Ramsey S; Unger JM
    Breast Cancer Res Treat; 2020 Jun; 181(2):455-463. PubMed ID: 32306168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Evaluation of Medical Conditions Associated with Risk of Non-Hodgkin Lymphoma using Medicare Claims ("MedWAS").
    Engels EA; Parsons R; Besson C; Morton LM; Enewold L; Ricker W; Yanik EL; Arem H; Austin AA; Pfeiffer RM
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1105-13. PubMed ID: 27197296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicare Utilization and Spending Among Nurses Compared with the General United States Population.
    Kapadia NS; Austin AM; Carmichael DQ; Wang Q; Erekson ED; Feskanich D; Grodstein F; Tosteson ANA; Bynum JPW
    J Womens Health (Larchmt); 2018 Dec; 27(12):1466-1473. PubMed ID: 30118370
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
    Abuamsha H; Kadri AN; Hernandez AV
    Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical costs associated with non-Hodgkin's lymphoma in the United States during the first two years of treatment.
    Kutikova L; Bowman L; Chang S; Long SR; Arning M; Crown WH
    Leuk Lymphoma; 2006 Aug; 47(8):1535-44. PubMed ID: 16966264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis.
    Shah NN; Ahn KW; Litovich C; Fenske TS; Ahmed S; Battiwalla M; Bejanyan N; Dahi PB; Bolaños-Meade J; Chen AI; Ciurea SO; Bachanova V; DeFilipp Z; Epperla N; Farhadfar N; Herrera AF; Haverkos BM; Holmberg L; Hossain NM; Kharfan-Dabaja MA; Kenkre VP; Lazarus HM; Murthy HS; Nishihori T; Rezvani AR; D'Souza A; Savani BN; Ulrickson ML; Waller EK; Sureda A; Smith SM; Hamadani M
    Blood Adv; 2018 Apr; 2(8):933-940. PubMed ID: 29685953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs associated with follicular lymphoma among individuals diagnosed with non-Hodgkin lymphoma: a longitudinal analysis using SEER-Medicare data.
    Albarmawi H; Nagarajan M; Sun K; Gandhi AB; Yared J; Keating KN; Appukkuttan S; Yaldo A; Gharibo M; Onukwugha E
    Leuk Lymphoma; 2020 Jan; 61(1):75-83. PubMed ID: 31389296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of lay navigation on utilization and Medicare spending for cancer survivors in the "Deep South".
    Williams CP; Rocque GB; Azuero A; Kenzik KM; Williams GR; Sharma P; Rocconi RP; Demark-Wahnefried W; Martin MY; Pisu M
    J Cancer Surviv; 2022 Aug; 16(4):705-713. PubMed ID: 34152532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare utilization, Medicare spending, and sources of patient distress identified during implementation of a lay navigation program for older patients with breast cancer.
    Rocque GB; Williams CP; Jones MI; Kenzik KM; Williams GR; Azuero A; Jackson BE; Halilova KI; Meneses K; Taylor RA; Partridge E; Pisu M; Kvale EA
    Breast Cancer Res Treat; 2018 Jan; 167(1):215-223. PubMed ID: 28900752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Febrile neutropenia-related care and associated costs in elderly patients with breast cancer, lung cancer, or non-Hodgkin lymphoma.
    Li S; Liu J; Bowers C; Garawin TAFS; Kim C; Bensink ME; Chandler DB
    Support Care Cancer; 2020 Jan; 28(1):113-122. PubMed ID: 30993450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of preventable acute care spending to total spending for high-cost Medicare patients.
    Joynt KE; Gawande AA; Orav EJ; Jha AK
    JAMA; 2013 Jun; 309(24):2572-8. PubMed ID: 23797716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
    Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
    J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing Cancer Treatment Information Using Medicare and Hospital Discharge Data among Women with Non-Hodgkin Lymphoma in a Los Angeles County Case-Control Study.
    Zhong C; Seibold P; Chao CR; Cozen W; Song JY; Weisenburger D; Bernstein L; Wang SS
    Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):936-941. PubMed ID: 32066614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.